Poseida Therapeutics, Inc. - Common Stock, par value $0.0001 per share (PSTX)

67 filings reported holding PSTX - Poseida Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q4 2020.
Poseida Therapeutics, Inc. - Common Stock, par value $0.0001 per share (PSTX) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 26.3M shares of 98.4M outstanding shares and own 26.78% of the company stock.
Largest 10 shareholders include FMR LLC (9.27M shares), Pentwater Capital Management LP (4.97M shares), BlackRock Inc. (1.55M shares), MILLENNIUM MANAGEMENT LLC (1.47M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.45M shares), BOXER CAPITAL, LLC (1.25M shares), Aisling Capital Management LP (1.04M shares), Vivo Capital, LLC (926K shares), Sectoral Asset Management Inc (839K shares), and PERCEPTIVE ADVISORS LLC (788K shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.